AAN 2022 | Future research directions for neuropsychiatric symptoms in Alzheimer’s disease

Corinne Fischer, MD, University of Toronto, Toronto, Canada, explains how we need to look across the fields of neurodegenerative disease and neuropsychiatric disease for a full understanding of the mechanisms underlying neuropsychiatric symptoms in Alzheimer’s disease. There is still not a comprehensive understanding of the biological mechanisms underlying other disorders in these fields, so there is a possibility of the same processes being involved in the development of common symptoms found in several diseases. Dr Fischer also discusses the need to investigate how neuropsychiatric symptoms affect the development of neurodegenerative disease. Finally, there is a need to further investigate the subtypes of neuropsychiatric symptoms and to develop effective treatments for these symptoms. This interview took place at the American Academy of Neurology 2022 Congress in Seattle, WA.